tresr trial: novel atr inhibitor, rp-3500, for advanced solid tumors
Published 2 years ago • 202 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
3:05
investigating the atr inhibitor elimusertib in advanced solid tumors
-
1:40
phase i study of the atr inhibitor m1774 in patients with solid tumors
-
2:01
patriot: atr inhibitor monotherapy in advanced solid tumors
-
2:22
tresr trial: investigating an atri in patients with dna damage repair loss-of-function mutant tumors
-
1:16
medi1191 with durvalumab in advanced solid tumors
-
1:27
new solid tumors clinical trial: bms-986315 for solid tumors, advanced solid tumors
-
1:32
new advanced solid tumors clinical trial: amg 193 for advanced mtap-null solid tumors
-
2:38
an exciting new combination to treat advanced solid tumors
-
2:14
novel immunotherapy and small molecule inhibitor combinations
-
1:25
new solid tumors clinical trial: ndi-101150 for solid tumors
-
2:46
rv-471: novel protac® estrogen receptor degrader, in er breast cancer
-
2:17
updates on the flt3 inhibitor ff-10101 for the treatment of r/r aml
-
2:16
clinical trial: astx295 for solid tumors (nct03975387)
-
1:13
solid tumor trials
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
6:11
targeted therapy for advanced solid tumors based on molecular profiles: early results from mypathway
-
44:32
interventional immunotherapy: transforming the treatment of solid tumors
-
1:43
clinical trials for solid tumors